Evaluation of the impact of timing of pegfilgrastim administration on incidence of febrile neutropenia in elderly patients with B-cell non-Hodgkin lymphomas receiving R-CHOP-21

Saved in:
Bibliographic Details
Published in:Leukemia & lymphoma 2020-10, Vol.61 (12), p.2998-3001
Main Authors: Lei, Matthew M., Watson, Aleksandra N., Abramson, Jeremy S.
Format: Article
Language:English
Subjects:
Aged
Antineoplastic Combined Chemotherapy Protocols - adverse effects
B-Lymphocytes
Febrile Neutropenia - drug therapy
Febrile Neutropenia - epidemiology
Febrile Neutropenia - prevention & control
Filgrastim - therapeutic use
Granulocyte Colony-Stimulating Factor - therapeutic use
Humans
Incidence
Lymphoma, Non-Hodgkin - complications
Lymphoma, Non-Hodgkin - drug therapy
Lymphoma, Non-Hodgkin - epidemiology
Polyethylene Glycols - therapeutic use
Recombinant Proteins
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1042-8194
1029-2403
DOI:10.1080/10428194.2020.1795157